Subarachnoid Hemorrhage and Soluble Epoxide Hydrolase Inhibition Trial "SUSHI"

Not yet recruiting

Phase 1/2 Results N/A

Summary of Purpose

Soluble epoxide hydrolase (sEH) is the metabolizing enzyme of epoxyeicosatrienoic acids (EETs), which may play a role in reducing neuroinflammation and regulating cerebral blood flow after subarachnoid hemorrhage (SAH). Hypotheses: Pharmacologic inhibition of the sEH enzyme is safe and will result in increased EETs availability in the blood and cerebrospinal fluid. This study is a double-blind,...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 18 October 2017.

31 Jan 2018 10 Oct 2017 30 Jun 2021 31 Dec 2021 1 Oct 2017 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

Not available

Contacts